Rehmann Capital Advisory Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Rehmann Capital Advisory Group’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-4,478	Closed	-$241K	–	2091
2017 Q4	$241K	Buy	+4,478	New	+$245K	0.04%	334
2017 Q3	–	Sell	-3,909	Closed	-$235K	–	405
2017 Q2	$235K	Buy	+3,909	New	+$223K	0.04%	312

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Rehmann Capital Advisory Group's BIVV Position: Q1 2018 in Review

Rehmann Capital Advisory Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 4,478 shares — an estimated $241K sold.

Rehmann Capital Advisory Group first reported a position in BIVV in Q2 2017 and held it in 2 quarters. The position peaked at $241K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Rehmann Capital Advisory Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Rehmann Capital Advisory Group sold 4,478 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $241K.
Rehmann Capital Advisory Group first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 2 quarters.
Rehmann Capital Advisory Group's Bioverativ Inc. Common Stock position peaked at $241K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Rehmann Capital Advisory Group's 13F filing for Q1 2018, filed 24 Apr 2018.